Data Availability
Data sharing is not applicable to this article as no new data were created or analyzed in this study.
Abbreviations
- MMSE :
-
Mini-mental state examination
References
AJ L (2011) A dictionary of neurological signs, in: r. edition (Ed.) Springer, New York
Kim EJ, Lee BH, Park KC, Lee WY, Na DL (2005) Micrographia on free writing versus copying tasks in idiopathic Parkinson’s disease. Parkinsonism Relat Disord 11(1):57–63
Inzelberg R, Plotnik M, Harpaz NK, Flash T (2016) Micrographia, much beyond the writer’s hand. Parkinsonism Relat Disord 26:1–9
Wu T, Zhang J, Hallett M, Feng T, Hou Y, Chan P (2016) Neural correlates underlying micrographia in Parkinson’s disease. Brain 139(Pt 1):144–160
Zham P, Poosapadi SA, Kempster P, Raghav S, Nagao KJ, Wong K, Kumar D (2021) Differences in levodopa response for progressive and non-progressive micrographia in Parkinson’s disease. Front Neurol 12:665112
Eklund M, Nuuttila S, Joutsa J, Jaakkola E, Makinen E, Honkanen EA, Lindholm K, Vahlberg T, Noponen T, Ihalainen T, Murtomaki K, Nojonen T, Levo R, Mertsalmi T, Scheperjans F, Kaasinen V (2022) Diagnostic value of micrographia in Parkinson’s disease: a study with [(123)I]FP-CIT SPECT. J Neural Transm (Vienna) 129(7):895–904
Ling H, Massey LA, Lees AJ, Brown P, Day BL (2012) Hypokinesia without decrement distinguishes progressive supranuclear palsy from Parkinson’s disease. Brain 135(Pt 4):1141–1153
Miguelez C, De Deurwaerdere P, Sgambato V (2020) Editorial: Non-dopaminergic systems in Parkinson’s disease. Front Pharmacol 11:593822
Klein JC, Eggers C, Kalbe E, Weisenbach S, Hohmann C, Vollmar S, Baudrexel S, Diederich NJ, Heiss WD, Hilker R (2010) Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo. Neurology 74(11):885–892
Xu Y, Yan J, Zhou P, Li J, Gao H, Xia Y, Wang Q (2012) Neurotransmitter receptors and cognitive dysfunction in Alzheimer’s disease and Parkinson’s disease. Prog Neurobiol 97(1):1–13
Mallet N, Leblois A, Maurice N, Beurrier C (2019) Striatal cholinergic interneurons: how to elucidate their function in health and disease. Front Pharmacol 10:1488
Wagle Shukla A, Ounpraseuth S, Okun MS, Gray V, Schwankhaus J, Metzer WS (2012) Micrographia and related deficits in Parkinson’s disease: a cross-sectional study. BMJ Open 2(3):e000628
Lange KW, Mecklinger L, Walitza S, Becker G, Gerlach M, Naumann M, Tucha O (2006) Brain dopamine and kinematics of graphomotor functions. Hum Mov Sci 25(4–5):492–509
Author information
Authors and Affiliations
Contributions
Concept – H.O.; design – H.O.; supervision – S.C.; materials – H.O, S.C.; data collection and/or processing – H.O., S.C.; analysis and/or interpretation – HO., S.C.; literature search – H.O; writing manuscript – H.O.; critical review – S.C.
Corresponding author
Ethics declarations
Ethical approval
Not applicable.
Informed consent
The consent form has been obtained from the patient and his spouse.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Onder, H., Comoglu, S. The significance of micrographia as a clinical feature of Parkinson’s disease and underlying pathophysiology. Neurol Sci 44, 1791–1793 (2023). https://doi.org/10.1007/s10072-022-06590-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-022-06590-y